Sunshine Lake Pharma Co., Ltd. (HKG:6887)
Hong Kong · Delayed Price · Currency is HKD 36.96
+0.38 (1.04%)
Sep 11, 2026, 4:08 PM HKT
Sunshine Lake Pharma Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 3,953 | 4,815 | 4,019 | 6,295 | 3,745 | 913.79 |
Revenue Growth | -17.91% | 19.81% | -36.15% | 68.08% | 309.83% | -61.08% |
Gross Profit Gross Profit Growth | 2,796 | 3,685 | 3,059 | 4,986 | 2,846 | 483.7 |
Operating Income Operating Income Growth | 72.49 | 691.16 | 358.81 | 2,790 | 322.72 | -458.11 |
Net Income Net Income Growth | -284.91 | 272.44 | -207.43 | 1,993 | 76.6 | -587.65 |
Earnings Per Share EPS Growth | -0.52 | 0.55 | -0.47 | 8.57 | 0.33 | -2.54 |
EPS Growth | - | - | - | 2496.14% | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Peoples Republic of China (PRC) Peoples Republic of China (PRC) Growth | 3,857 | 4,725 | 3,880 | 6,295 | 3,745 | 913.79 |
Overseas Overseas Growth | 95.23 | 90.28 | 138.43 | - | - | - |
Total Total Growth | 3,953 | 4,815 | 4,019 | 6,295 | 3,745 | 913.79 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 1,489 | 1,503 | 1,485 | 1,674 | 1,214 | 1,131 |
Total Debt Total Debt Growth | 5,313 | 4,680 | 4,624 | 2,609 | 3,822 | 3,194 |
Net Cash (Debt) Net Cash Growth | -3,824 | -3,177 | -3,140 | -934.92 | -2,608 | -2,062 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -7.03 | -6.38 | -7.12 | -4.03 | -11.24 | -8.89 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | - | 1,155 | 500.53 | 1,673 | 1,700 | -662.51 |
Capital Expenditures CapEx Growth | - | -836.04 | -1,062 | -343.72 | -570.07 | -356.29 |
Free Cash Flow Free Cash Flow Growth | - | 319.14 | -561.37 | 1,329 | 1,130 | -1,019 |
Free Cash Flow Growth | - | - | - | 17.67% | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 70.73% | 76.54% | 76.11% | 79.21% | 76.00% | 52.93% |
Operating Margin | 1.83% | 14.35% | 8.93% | 44.33% | 8.62% | -50.13% |
Pretax Margin | -5.69% | 9.13% | 3.51% | 33.79% | 1.05% | -73.01% |
Profit Margin | -7.21% | 5.66% | -5.16% | 31.66% | 2.05% | -64.31% |
FCF Margin | - | 6.63% | -13.97% | 21.12% | 30.17% | -111.49% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 11, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 5.690 | - | - | - | - | - |
Dividend Per Share Growth | 0% | - | - | - | - | - |
Dividend Yield | 15.74% | - | - | - | - | - |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 11, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | - | 86.66 | - | 3.80 | 66.05 | - |
P/FCF Ratio | - | 73.98 | - | 5.70 | 4.48 | - |
PS Ratio | 4.61 | 4.90 | 1.97 | 1.20 | 1.35 | 4.79 |